Die Bedeutung der Bluttransfusion in der kolorektalen Tumorchirurgie

K. Pfister; B. Dietl; A. Fürst; G. Multhoff; K.-W. Jauch

doi:10.1055/s-2002-32389

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000091.xml

Share / Bookmark

Facebook Linkedin Weibo

Download PDF

Viszeralchirurgie 2002; 37(3): 250-258
DOI: 10.1055/s-2002-32389

Originalarbeit

Die Bedeutung der Bluttransfusion in
der kolorektalen Tumorchirurgie

Significance of blood transfusion in colorectal cancerK. Pfister¹ , B. Dietl² , A. Fürst¹ , G. Multhoff³ , K.-W. Jauch¹

¹Chirurgische Klinik und Poliklinik der Universität Regensburg
²Strahlentherapie der Universität Regensburg
³Hämatologie und internistische Onkologie der Universität Regensburg, AG Natürliche Killerzellen

Further Information

Publication History

Publication Date:
20 June 2002 (online)

Abstract
Full Text
References

Permissions and Reprints

Zusammenfassung

Mehr als die Hälfte aller Patienten mit kolorektalem Karzinom wird durch die tumorinduzierte Anämie und den perioperativen Blutverlust transfusionsbedürftig. Obwohl bisher der kausale Mechanismus nicht bekannt ist, gilt die fremdblutassoziierte Immunsuppression experimentell und klinisch als bewiesen. Eine Erhöhung der postoperativen Infektionsrate durch die Transfusion wird übereinstimmend bejaht, die Beeinträchtigung der Tumorprognose sowie eine erhöhte Rezidivrate jedoch kontrovers diskutiert. In dieser Übersichtsarbeit wurde die Literatur zum gesamten Themenkomplex zusammengetragen und analysiert. Die überwiegend retrospektiven Daten lassen derzeit keine definitive Beurteilung der klinischen Auswirkungen des negativen Transfusionseffektes zu. Dennoch sollte der Risikofaktor Bluttransfusion möglichst vermieden werden.

Abstract

More than half of all patients with colorectal cancer need blood transfusion because of tumor induced anemia or perioperative blood loss. Transfusion associated immunosuppression is a well known phenomenon although underlying mechanism is still not understood. Whereas in most studies concerning postoperative infection rate allogeneic blood transfusion had been an independent risk factor, controversial data have been published regarding the influence on colorectal cancer prognosis and tumor recurrence. The review analyzed the literature currently available. Clinical consequences of mainly retrospective surveys remain unclear. Therefore we suggest to avoid homologous blood transfusion wherever possible.

Schlüsselwörter

Anämie - Bluttransfusion - kolorektales Karzinom - postoperative Infektionsrate - Tumorprognose

Key words

Tumor induced anemia - Blood transfusion - Colorectal cancer - Postoperative infection rate - Cancer prognosis

Literatur

1 Hansen E, Taeger K, Hofstädter F. Die Retransfusion von Wundblut bei Tumorpatienten. Dtsch Ärzteblatt. 1999; 41 B2097-2102

PubMed Search in Google Scholar
2 Messmer K. Roundtable of Experts in Surgery Blood Management-Consensus Statement. Infusionsther Transfusionmed. 1996; 23 143-146

PubMed Search in Google Scholar
3 Kettelhack C, Hoenes C, Messinger D, Schlag P M. Randomized multicentre trial of the influence of recombinant human erythropoietin on intraoperative and postoperative transfusion need in anaemic patients undergoing right hemicolectomy for carcinoma. Br J Surg. 1998; 85 63-67

Crossref PubMed Search in Google Scholar
4 Geissmann D, Laffer U, Maibach R, Metzger U. SAKK . Transfusionsverhalten bei kurativ operierten Patienten mit kolorektalen Karzinomen. Zentralbl Chir. 2000; 125 847-851

Thieme Connect PubMed Search in Google Scholar
5 Harder F, Laffer U, Berres M, Jäggi P, Metzger U. SAKK . Nach kurativer Resektion colorectaler Carcinome wirkt die portale Chemotherapie vor allem beim nicht-transfundierten Patienten. Chirurg. 1990; 61 280-285

PubMed Search in Google Scholar
6 Swiss Group for Clinical Cancer Research (SAKK) . Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. Eur J Surg. 1997; 163 693-701

PubMed Search in Google Scholar
7 Nicholls M D, Whyte G. Red cell, plasma and albumin transfusion decision triggers. Anaesth Intens Care. 1993; 21 156-162

PubMed Search in Google Scholar
8 Hallissey M T, Crowson M C, Kiff R S, Kingston R D, Fielding J W. Blood transfusion: an overused resource in colorectal cancer surgery. Ann R Coll Surg Engl. 1992; 74 59-62

PubMed Search in Google Scholar
9 American College of Physicians . Practice strategies for elective red blood cell transfusion. Ann Intern Med. 1991; 116 403-406

PubMed Search in Google Scholar
10 Standards for Blood Banks and Transfusion Services . Prepared by Committee on Standards. American Association of Blood Banks. 1993; 15 35-38

PubMed Search in Google Scholar
11 Sirchia G, Giovanetti A M. et al .Safe and good use of blood in surgery (SANGUIS). Use of blood products and artificial colloids in 43 European hospitals. Luxemburg: European Commission 1994

Search in Google Scholar
12 Houston F, Foster J B, Chong A. et al . Transmissioin of BSE by blood transfusion in sheep. Lancet. 2000; 356 999-1000

Crossref PubMed Search in Google Scholar
13 Dodd R Y. Adverse consequences of blood transfusion: quantitative risk estimates. Nance ST ed Blood supply: risks, perceptions and prospects for the future. Bethesda: American Association of Blood Banks 1994: 1-24

Search in Google Scholar
14 Taleghani M, Reith H B, Wiebecke D, Thiede A. Hämotherapie in der operativen Medizin. Zentralbl Chir. 1999; 4 W27-41

PubMed Search in Google Scholar
15 Opelz G, Sengar D PS, Mickey M R, Terasaki P I. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc. 1973; 5 253-259

PubMed Search in Google Scholar
16 Opelz G, Terasaki P I. Improvement of kidney-graft survival with increased numbers of transfusions. N Engl J Med. 1978; 299 799-803

PubMed Search in Google Scholar
17 Heiss M M, Delanoff C. Immunmodulatorische Wirkung der Bluttransfusion und Einfluss auf Infektionsrate und Tumorrezidiv. Infusionsther Transfusionmed. 1997; 24 20-31

PubMed Search in Google Scholar
18 Houbiers J G, van de Velde C J, van de Watering L M, Hermans J, Schreuder S, Bijnen A B, Pahlplatz P, Schattenkerk M E, Wobbes T, de Vries J E, Klementschitsch P, van de Maas A H, Brand A. Transfusion of red cells in associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion. 1997; 37 126-134

Crossref PubMed Search in Google Scholar
19 Schricker K T, Hermanek P, Guggenmoos-Holzmann I, Neidhardt B, Resch T, Freudenberger K. Verschlechterung des Überlebens bei kolorektalem Karzinom. Überraschende Ergebnisse einer Multivarianzanalyse. Beitr Infusionsther. 1990; 26 307-312

PubMed Search in Google Scholar
20 Marsh J, Donnan P T, Hamer-Hodges D W. Association between transfusion with plasma and the recurrence of colorectal carcinoma. Br J Surg. 1990; 77 623-626

PubMed Search in Google Scholar
21 Blajchman M A, Bordin J O. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol. 1994; 1 457-461

PubMed Search in Google Scholar
22 Waymack J P, Alexander J W. Blood transfusion as an immunomodulator: a review. Comp Immunol Microbiol Infect Dis. 1986; 9 177-183

PubMed Search in Google Scholar
23 Blumberg N, Heal J M. Transfusion and recipient immune function. Arch Pathol Lab Med. 1989; 113 246-253

PubMed Search in Google Scholar
24 Roth J A, Golub S H, Grimm E A, Eilber F R, Morton D L. Effects of operation on immune response in cancer patients: sequential evaluation of in vitro lymphocyte function. Surgery. 1976; 79 46-51

PubMed Search in Google Scholar
25 Hunt P S, Trotter S. Lymphocyte response after surgery and blood transfusion. J Surg Res. 1976; 21 57-64

Crossref PubMed Search in Google Scholar
26 Peller S, Sayfan J, Levy Y, Oland J, Yona R, Kaufman S, Orda R. Immunological profile changes following perioperative autologous vs. homologous blood transfusion in oncologic patients. J Surg Oncol. 1994; 56 98-101

PubMed Search in Google Scholar
27 Brivio F, Lissoni P, Redaelli R, Maggioni A, Rovelli F, Rescaldani R, Borin F, Erba L, Alderi G. Influence of blood transfusions on surgery-induced immune changes in colorectal carcinoma. Miner Chir. 1993; 48 331-335

PubMed Search in Google Scholar
28 Tartter P I, Steinberg B, Barron D, Martinelli G. Transfusion History, T Cell subsets and Natural killer cytotoxicity in Patients with colorectal cancer. Vox Sang. 1989; 56 80-84

PubMed Search in Google Scholar
29 Jensen L S, Andersen A J, Christiansen P M. et al . Post-operative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1992; 79 513-516

PubMed Search in Google Scholar
30 Ishijima N, Suzuki H. Blood transfusion and postoperative serum interleukin-6 levels in colorectal cancer patients. Hepato-Gastroenterol. 1998; 45 1011-1013

PubMed Search in Google Scholar
31 Ziv Y, Shohat B, Gelerenter I, Wolloch Y. The influence of perioperative transfusions on the immunological profile of patients with colorectal adenocarcinoma. Panminerva Med. 1992; 34 4-12

PubMed Search in Google Scholar
32 Mathiesen O, Lund L, Brodthagen U, Gandrup P, Grunnet N, Balslev I, Jersild C. The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer. Vox Sang. 1994; 67 36-41

PubMed Search in Google Scholar
33 Gantt C L. Red blood cells for cancer patients (letter). Lancet. 1981; ii 363

PubMed Search in Google Scholar
34 van de Watering L MG. et al . Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery. Circulation. 1998; 97 562-568

PubMed Search in Google Scholar
35 Tartter P I, Quintero S, Barron D M. Perioperative Blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg. 1986; 152 479-482

Crossref PubMed Search in Google Scholar
36 Duffy G, Neal K R. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion - a meta-analysis of published randomized and nonrandomized studies. Transfus Med. 1996; 6 325-328

PubMed Search in Google Scholar
37 Tartter P I. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg. 1988; 75 789-792

PubMed Search in Google Scholar
38 Chiarugi M, Buccianti P, di Sarli M, Galatioto C, Goletti O, Cavina E. Association between perioperative blood transfusion and dehiscence of anastomosis after rectal resection for cancer. Acta Chir Belg. 1996; 96 108-111

PubMed Search in Google Scholar
39 Ford C D, VanMoorleghem G, Menlove R L. Blood transfusions and postoperative wound infection. Surgery. 1993; 113 603-607

PubMed Search in Google Scholar
40 Vignali A, Braga M, Gianotti L, Radaelli G, Gentilini O, Russo A, di Carlo V. A single unit of transfused allogeneic blood increases postoperative infections. Vox Sang. 1996; 71 170-175

Crossref PubMed Search in Google Scholar
41 Jaberth A V, Lee E T, Hersch E M, McBride C M. Effects of surgery, anesthesia and intraoperative blood loss on immunocompetence. J Surg Res. 1973; 15 399-403

Crossref PubMed Search in Google Scholar
42 Heald R J, Ryall R D. Recurrence and survival after total mesorectal excision after rectal cancer. Lancet. 1986; 2 1479-1482

PubMed Search in Google Scholar
43 Vamvakas E C, Carven J H. Transfusion of white-cell containing allogeneic blood components and postoperative wound infection: effect of confounding factors. Transfusion Med. 1998; 8 29-36

PubMed Search in Google Scholar
44 Vamvakas E C, Carven J H, Hibberd P L. Blood Transfusion and infection after colorectal cancer surgery. Transfusion. 1996; 36 1000-1008

Crossref PubMed Search in Google Scholar
45 Jensen L S, Hokland M, Nielsen H J. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br J Surg. 1996; 83 973-977

PubMed Search in Google Scholar
46 Jensen L S, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet. 1996; 348 841-845

Crossref PubMed Search in Google Scholar
47 Heiss M M, Mempel W, Jauch K W, Delanoff C, Mayer G, Mempel M, Eissner H J, Schildberg F W. Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgery. Lancet. 1993; 342 1328-1333

Crossref PubMed Search in Google Scholar
48 Heiss M M, Mempel W, Delanoff C, Mempel M, Jauch K W, Schildberg F W. Klinische Auswirkungen der mit einer Bluttransfusion assoziierten Immunmodulation auf das Ergebnis der Tumoroperation. Infusionsther Transfusionsmed. 1993; 20 (Suppl 2) 25-29

PubMed Search in Google Scholar
49 Jensen L S, Heiss M M, Mempel W, Jauch K W, Schildberg F W, Ross W B, Houbiers J GA, van de Watering L MG, Verwey P JM, van de Velde C JH, Brand A. Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994; 344 1429-1431

Crossref PubMed Search in Google Scholar
50 Houbiers J G, Brand A, van de Watering L M, Hermans J, Verwey P J, Bijnen A B, Pahlplatz P, Eeftinck S chattenkerk, Wobbes T, de Vries J E. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet. 1994; 344 573-578

Crossref PubMed Search in Google Scholar
51 Busch O RC, Hop W CI, van Papendrecht M AV, Marquet R L, Jeekel J. Blood transfusions and prognosis in colorectal cancer. N Engl J Med. 1993; 328 1372-1376

Crossref PubMed Search in Google Scholar
52 Vignali A, Braga M, Dionigi P, Radaelli G, Gentilini O, Bellini A, Jemos V, di Carlo V. Impact of a programme of autologous blood donation on the incidence of infection in patients with colorectal cancer. Eur J Surg. 1995; 161 487-492

PubMed Search in Google Scholar
53 Parrot N R, Lennard T W, Taylor R M, Proud G, Shenton B K, Johnston I D. Effects of perioperative blood transfusion on recurrence of colorectal cancer. Br J Surg. 1986; 73 970-973

PubMed Search in Google Scholar
54 Burrows L, Tartter P, Aufses A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients. Cancer Detect Prev. 1987; 10 361-369

PubMed Search in Google Scholar
55 Creasy T S, Veitch P S, Bell P R. A relationship between perioperative blood transfusion and recurrence of carcinoma of the sigmoid colon following potentially curative surgery. Ann R Coll Surg Engl. 1987; 69 100-103

PubMed Search in Google Scholar
56 Beynon J, Davies P W, Billings P J. et al . Perioperative blood transfusion increases the risk of recurrence in colorectal cancer. Dis Colon Rectum. 1989; 29 975-979

PubMed Search in Google Scholar
57 Mecklin J P, Jarvinen J H, Ovaska J T. Blood transfusion and prognosis in colorectal carcinoma. Scand J Gastroenterol. 1989; 24 33-39

PubMed Search in Google Scholar
58 Wobbes T, Joosen K H, Kuypers H H, Beerthuizen G I, Theeuwes A G. The effect of packed cells and whole blood transfusions on survival after curative resection for colorectal carcinoma. Dis Colon Rectum. 1989; 32 743-748

PubMed Search in Google Scholar
59 Blumberg N, Chuang-Stein C, Heal J M. The relation-ship of blood transfusion, tumor staging, and cancer recurrence. Transfusion. 1990; 30 291-294

Crossref PubMed Search in Google Scholar
60 Kijems E, Schydlowski P, Sondergaard J O. The influence of blood transfusions upon the recurrence rate of colorectal cancer. Rev Med Chir Soc Med Nat Iasi. 1991; 95 265-268

PubMed Search in Google Scholar
61 Tang R, Wang J Y, Chang-Chien C R, Chen J S, Lin S E, Hong A F. The asssociation between perioperative blood transfusion and survival of patients with colorectal cancer. Cancer. 1993; 72 341-348

PubMed Search in Google Scholar
62 Frankish P D, McNee R K, Alley P G, Woodfield D G. Relation between cancer of the colon and blood transfusion. BMJ. 1985; 290 1827

PubMed Search in Google Scholar
63 Francis D M, Judson R T. Blood transfusion and recurrence of cancer of the colon. Br J Surg. 1987; 74 26-30

PubMed Search in Google Scholar
64 van Lawick X, Pabst W P, Lagenhorst B L, Mulder P G, Marquet R L, Jeekel J. Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival. Eur J Cancer Clin Oncol. 1988; 24 741-747

Crossref PubMed Search in Google Scholar
65 Cheslyn-Curtiss S, Fielding L P, Hittinger R, Fry J S, Phillips R K. Large bowel cancer: the effect of perioperative blood transfusion on outcome. Ann R Coll Surg Engl. 1990; 72 53-59

PubMed Search in Google Scholar
66 Edna T H, Bjerkeset T. Perioperative blood transfusions reduce long-term survival following surgery for colorectal cancer. Dis Colon Rectum. 1998; 41 451-459

PubMed Search in Google Scholar
67 The Swiss Group for Clinical Cancer Research . Association between blood transfusion and survival in a randomised multicentre trial of perioperative adjuvant portal chemotherapy in patients with colorectal cancer. Eur J Surg. 1997; 163 693-701

PubMed Search in Google Scholar
68 Hermanek P. Beeinflussen perioperative Bluttransfusionen die Prognose von Patienten mit kolorektalem Karzinom?. Strahlenther Onkologie. 1996; 172 283-284

PubMed Search in Google Scholar
69 Blumberg N, Heal J M. Perioperative blood transfusion and colorectal cancer recurrence. Transfusion. 1994; 34 450-452

Crossref PubMed Search in Google Scholar
70 Leite J F, Granjo M E, Martins M I, Reis R C, Monteiro J C, Castro-Sousa F. Effect of perioperative blood transfusions on survival of patients after radical surgery for colorectal cancer. Int J Colorectal Dis. 1993; 8 129-133

Crossref PubMed Search in Google Scholar
71 Jahnson S, Andersson M. Adverse effects of perioperative blood transfusion in patients with colorectal cancer. Eur J Surg. 1992; 158 419-425

PubMed Search in Google Scholar
72 Faenza A, Cusolo A, Selleri S, Lucarell S, Farneti P A, Gozzetti G. Correlation between plasma or blood transfusion and survival after curative surgery for colorectal cancer. Int Surg. 1992; 77 264-269

PubMed Search in Google Scholar
73 Tartter P I. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg. 1992; 216 633-638

PubMed Search in Google Scholar
74 Zimmermann T, Dobroschke J, Borowek U, Padberg W. Der Einfluss der perioperativen Fremdblutgabe auf die Prognose des kolorektalen Karzinoms. Zentralbl Chir. 1991; 116 1125-1138

PubMed Search in Google Scholar
75 Weiden P L. Do perioperative blood transfusions increase the risk of cancer recurrence?. Eur J Cancer. 1990; 26 987-989

PubMed Search in Google Scholar
76 Liewald F, Wirsching R P, Zuelke C, Demmel N, Mempel W. Influence of blood transfusions on tumor recurrence and survival rate in colorectal carcinoma. Eur J Cancer. 1990; 26 327-335

PubMed Search in Google Scholar
77 Freiman J A, Chalmers T C, Smith H, Kuebler R R. The importance of beta, the type II error and sample size in the design and interpretation of randomized controlled trial. N Engl J Med. 1978; 299 690-694

PubMed Search in Google Scholar
78 Chung M, Steinmetz O K, Gordon P H. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg. 1993; 80 427-432

PubMed Search in Google Scholar
79 Vamvakas E, Moore S B. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion. 1993; 33 754-765

Crossref PubMed Search in Google Scholar
80 Vamvakas E C. Perioperative blood transfusion und cancer recurrence: meta-analysis for explanation. Transfusion. 1995; 35 760-768

Crossref PubMed Search in Google Scholar
81 Amato A C, Pescatori M. Effect of perioperative blood transfusions on recurrence of colorectal cancer: Meta-analysis stratified on risk factors. Dis Colon Rectum. 1998; 41 570-585

Crossref PubMed Search in Google Scholar
82 Vamvakas E C. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion. 1996; 36 175-186

Crossref PubMed Search in Google Scholar
83 Busch O RC, Hop W CJ, Marquet R L, Jeekel J. Prognostic impact of blood transfusions on disease-free survival in colorectal carcinoma. Scand J Gastroenterol. 1993; (Suppl) 21-23

PubMed Search in Google Scholar
84 Busch O RC, Hop W CJ, Marquet R L, Jeekel J. The effect of blood transfusions on survival after surgery for colorectal cancer. Eur J Cancer. 1995; 31A 1226-1228

PubMed Search in Google Scholar
85 Molland G, Dent O F, Chapuis P H, Bokey E L, Nicholls M, Newland R C. Transfusion does not influence patient survival after resection of colorectal cancer. Aust Nz J Surg. 1995; 65 592-595

PubMed Search in Google Scholar
86 Donohue J H, Williams S, Cha S, Windschitl H E, Witzig T E, Nelson H, Fitzgibbons R J, Wieand H S, Moertel C G. Peroperative blood transfusions do not affect disease recurrence of patients undergoing curative resection of colorectal carcinoma: a Mayo/North Central Cancer Treatment Group study. J Clin Oncol. 1995; 13 1671-1678

PubMed Search in Google Scholar
87 Busch O R, Hop W C, Marquet R L, Jeekel J. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg. 1994; 220 791-797

PubMed Search in Google Scholar
88 Steup W H, Hojo K, Moriya Y, Sugihara K, Mizuno S, Hermans J, van de Velde C J. An analysis on the effect of blood transfusion on recurrence and survival in patients undergoing extended lymphadenectomy for colorectal cancer. Hepato-Gastroenterol. 1994; 41 253-259

PubMed Search in Google Scholar
89 Garau I, Benito E, Bosch F X, Bargay J, Obrador A, Santamaria J, Antich J L, Besalduch J, Rifa J, Teuchmann S. Blood transfusion has no effect on colorectal cancer survival. A population-based study. Eur J Cancer. 1994; 30A 759-764

PubMed Search in Google Scholar
90 Sibbering D M, Locker A P, Hardcactle J D, Armitage N C. Blood transfusion and survival in colorectal cancer. Dis Colon Rectum. 1994; 37 358-364

PubMed Search in Google Scholar
91 Ford C D, Gillette J W, Handrahan D L, Koehler C S. Transfusion and second malignancy. Transfusion. 1994; 34 63-65

Crossref PubMed Search in Google Scholar
92 Sene A, Jeacock J, Robinson C, Walsh S, Kingston R D. Blood transfusion does not have an adverse effect on survival after operation for colorectal cancer. Ann R Coll Surg Engl. 1993; 75 261-266

PubMed Search in Google Scholar
93 Modin S, Karlsson G, Wahlby L. Blood transfusion and recurrence of colorectal cancer. Eur J Surg. 1992; 158 371-375

PubMed Search in Google Scholar
94 Bentzen S M, Balslev I, Pedersen M, Teglbjaerg P S, Hanberg-Sorensen F, Bone J, Jacobsen N O, Sell A, Overgaard J, Bertelsen K. et al . Blood transfusion and prognosis in Dukes' B and C colorectal cancer. Eur J Cancer. 1990; 26 457-463

PubMed Search in Google Scholar
95 Jakobsen E B, Eickhoff J H, Andersen J, Lundvall L, Stenderup J K. Perioperative blood transfusion and recurrence and death after resection for cancer of the colon and rectum. Scand J Gastroenterol. 1990; 25 435-442

PubMed Search in Google Scholar
96 McAlister F A, Clark H D, Wells P S, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies. Br J Surg. 1998; 85 171-178

Crossref PubMed Search in Google Scholar
97 Busch O RC, Marquet R L, Hop W CI, Jeekel J. Colorectal cancer recurrence and perioperative blood transfusions: A critical reappraisal. Sem Surg Oncol. 1994; 10 195-199

PubMed Search in Google Scholar
98 Heiss M M, Mempel W, Delanoff C, Jauch K W, Gabka C, Mempel M, Dieterich H J, Eissner H J, Schildberg F W. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol. 1994; 12 1859-1867

PubMed Search in Google Scholar
99 Francis D MA. Relationship between blood transfusion and tumour behaviour. Br J Surg. 1991; 78 1420-1428

PubMed Search in Google Scholar
100 Nielsen H J. Detrimental effects of perioperative blood transfusion. Br J Surg. 1995; 82 582-587

PubMed Search in Google Scholar
101 Singh S K, Marquet R L, de Bruin R WF, Westbroek D L, Jeekel J. Promotion of tumour growth by blood transfusions. Transplant Proc. 1987; 19 1473-1474

PubMed Search in Google Scholar
102 Tartter P I, Francis D M. Blood transfusion and tumor growth. Transplant Proc. 1988; 20 1108-1111

PubMed Search in Google Scholar
103 Hebert P C. et al . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. NEJM. 1999; 340 409-417

PubMed Search in Google Scholar
104 Hogue C W, Goodnough L T, Monk T G. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion. 1998; 38 924-993

Crossref PubMed Search in Google Scholar
105 Marquet R L, de Bruin R W, Dallinga R, Singh S K, Jeekel J. Modulation of tumor growth by allogenic blood transfusion. J Cancer Res Clin Oncol. 1986; 11 50-53

PubMed Search in Google Scholar
106 Singh S K, Marquet R L, de Bruin R W, Hop W C, Westerbroek D L, Jeekel J. Consequences of blood loss on growth of artificial metastases. Br J Surg. 1988; 75 377-379

PubMed Search in Google Scholar
107 Francis D M, Shenton B K, Proud G, Taylor R M. Tumor growth and blood transfusion. J Exp Clin Cancer Res. 1982; 1 121-126

PubMed Search in Google Scholar
108 Eggermont A M, Stellar E P, Sugarbaker P H. Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells. Surgery. 1987; 102 71-78

PubMed Search in Google Scholar
109 Bordin J O, Bardossy L, Blajchman M A. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leucodepletion. Blood. 1994; 84 344-348

PubMed Search in Google Scholar
110 de Canniere L, Rosiere A, Michel L A. Synchronous abdominoperineal resection without transfusion. Br J Surg. 1993; 80 1194-1195

PubMed Search in Google Scholar
111 Taleghani M, Grossmann R, Reith H B, Wiebecke D, Thiede A. Fremdblutsparende Maßnahmen in der operativen Medizin. Zentralbl Chir. 2000; 125 111-122

PubMed Search in Google Scholar
112 Leben J, Schregel W. Ist perioperative Wärmung wirtschaftlich vertretbar oder ist Nicht-Wärmung heute noch wirtschaftlich vertretbar?. J Anästh Intensiv. 2001; 3 171-173

PubMed Search in Google Scholar
113 Siebeck M, Schorr M, Heckl U. et al .Effekt von Aprotinin auf Blutverlust und Transfusion beim Rektumresektionen. Postersitzung Viszeralchirurgie und Forschung. Wiss. Referate 77. Tagung Ver. Bayer. Chir 2000

Search in Google Scholar
114 Lentschener C, Benhamou D, Mercier F J. et al . Aprotinin reduces blood loss in patients undergoing elective liver resection. Anest Analg. 1997; 84 (4) 875-881

PubMed Search in Google Scholar
115 Porte R J, Molenaar I Q, Begliomini B. et al . Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet. 2000; 355 (9212) 1303-1309

Crossref PubMed Search in Google Scholar
116 Hedner U. Recombinant activated factor VIIa as a universal haemostatic agent. Blood Coag Fibrinol. 1998; 9 (Suppl 1) 147-152

PubMed Search in Google Scholar
117 Ehrenforth S. Therapeutic potential of recombinant activated factor VII in intensive care medicine. J Anästh Intensiv. 2001; 3 110-112

PubMed Search in Google Scholar
118 Larocque B J, Gilbert K, Brien W F. A point score system for predicting the likelihood of blood transfusion after hip or knee arthroplasty. Transfusion. 1997; 37 463-467

Crossref PubMed Search in Google Scholar
119 Hansen E, Altmeppen J, Taeger K. Autologous haemotherapy in malignant diseases. Clinical anaesthesiology: Blood, blood products and blood saving techniques. Kretschmer V, Blauhut B (eds). 1997 6: 335-350

Search in Google Scholar
120 Mac Douglas N. The patient's blood is the safest blood. N Engl J Med. 1987; 316 542-544

PubMed Search in Google Scholar
121 Mempel W, Lehr L. Präoperative Eigenblutspende und -bereitstellung. Chiurg. 1994; 65 1075-1079

PubMed Search in Google Scholar
122 Bormann von B, Aulich S. Autologe Transfusionsverfahren: Nutzen und Risiko. Dtsch Ärzteblatt. 1993; 90 2912-2918

PubMed Search in Google Scholar
123 Jaffray B. Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. Br J Surg. 1992; 79 977

PubMed Search in Google Scholar
124 Hoynck von X, Papendrecht M A, Hop W, Langenhorst B L, Kothe F C, Marquet R L, Jeekel J. Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: Results from a randomized clinical study. Vox Sang. 1992; 62 102-107

PubMed Search in Google Scholar
125 Harrison S, Steele R JC, Johnson A K. et al . Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. Br J Surg. 1992; 79 355-357

PubMed Search in Google Scholar
126 Linden J V, Wagner K, Voytovich A E, Sheehan J. Transfusion errors in New York State: an analysis of 10 years' experience. Transfusion. 2000; 40 1207-1213

Crossref PubMed Search in Google Scholar
127 Popovsky M A, Whitaker B, Arnold N L. Severe outcomes of allogeneic and autologous blood donation frequency and characterization. Transfusion. 1995; 35 734-737

Crossref PubMed Search in Google Scholar
128 Blutmanagement in der Chirurgie. Symposium St. Barbara Hospital Gladbeck
129 Kiesewetter H, Jung F, Koscielny J, Pindur G, Wenzel E. Qualitätssicherung bei der Eigenblutentnahme von kritisch Kranken. Beitr Infusionsther. 1993; 31 202-208

PubMed Search in Google Scholar
130 Heiss M M, Fraunberger P, Delanoff C, Stets R, Allgayer H, Stroehlein M A, Tarabichi A, Faist E, Jauch K W, Schildberg F W. Modulation of immune response by blood transfusion: evidence for a differential effect of allogeneic and autologous blood in colorectal cancer surgery. Shock. 1997; 8 402-408

Crossref PubMed Search in Google Scholar
131 Heiss M M, Fasol-Merten K, Allgayer H, Stroehlein M A, Tarabichi A, Wallner S, Eissner H I, Jauch K W, Schildberg F W. Influence of autologous versus allogeneic blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery. Vox Sang. 1997; 73 237-245

Crossref PubMed Search in Google Scholar
132 AuBuchon J P, Birkmeyer J D. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost? Transfusion. 1994; 34 79-83

PubMed Search in Google Scholar
133 Goldfinger D, Haimowitz M. Controversies in transfusion medicine. Is autologous blood transfusion worth the cost?. Transfusion. 1994; 34 75-78

Crossref PubMed Search in Google Scholar
134 Etchason J, Petz L, Keeler E. et al . The cost effectiveness of preoperative autologous blood donations. N Engl J Med. 1995; 332 719-724

Crossref PubMed Search in Google Scholar
135 Birkmeyer J D, AuBuchon J P, Littenberg B. et al . Cost-effectiveness of preoperative autologous donation in coronary artery bypass grafting. Ann Thorac Surg. 1994; 57 161-168

PubMed Search in Google Scholar
136 Birkmeyer J D, Goodnough L T, AuBuchon J P, Littenberg B. et al . The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion. 1993; 33 544-551

Crossref PubMed Search in Google Scholar
137 Lane T A. The effect of storage on the metastatic potential of tumor cells collected in autologous blood. Transfusion. 1989; 29 418-420

Crossref PubMed Search in Google Scholar
138 Mynster T, Nielsen H J. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Scand J Gastroenterol. 2000; 35 212-217

Crossref PubMed Search in Google Scholar
139 Marquet R L, Busch O R, Jeekel J, Heiss M M, Amato A C. Are allogeneic blood transfusions acceptable in elective surgery in colorectal carcinoma?. Eur J Cancer. 1999; 35 352-360

Crossref PubMed Search in Google Scholar
140 Edna T H, Bjerkeset T. Association between transfusion of stored blood and infective bacterial complications after resection for colorectal cancer. Eur J Surg. 1998; 164 449-456

Crossref PubMed Search in Google Scholar
141 Hoh H, Umpleby H, Cooper A, Taylor I. Recurrence of colorectal cancer and perioperative blood transfusion. Is blood storage time important?. Dis Colon Rectum. 1990; 33 127-130

PubMed Search in Google Scholar
142 Sibrowski W, Cassens U. Einfluss von Lagerung und Konservierung auf die Qualität von Blutzellen. Anästhesiol Intensivmed Notfallmed Schmerzther. 1998; 33 673-675

PubMed Search in Google Scholar
143 Blajchman M A. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang. 1998; 74 (Suppl 2) 315-319

PubMed Search in Google Scholar
144 Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten Hämotherapie. Neu bearbeitete Fassung. Deutscher Ärzte-Verlag Köln 2000

Search in Google Scholar
145 Prionen-Forschung und -Diagnostik. Vom BSE-Schnelltest bis zum Nachweis von Prionen im Blut. Dtsch Ärzteblatt 2000 49: B2786-2788

Search in Google Scholar
146 Turner M L, McClelland D BL. The role of r-HuEPO in surgical transfusion practice. Erythropoiesis. 1995; 6 107-113

PubMed Search in Google Scholar
147 Henry D H. Recombinant human erythropoietin in the treatment of the anemia associated with solid tumors. Bauer C, Koch KM et al Epo-molecular physiology and clinical applications. NY, Marcel Dekker 1994: 293ff

Search in Google Scholar
148 Heiss M M, Tarabichi A, Allgayer H, Jauch K W, Mempel W, Schildberg F W, Messmer K. Perisurgical erythropoietin application in anemic patients with colorectal cancer: a double-blind randomized study. Surgery. 1996; 5 523-527

PubMed Search in Google Scholar
149 Eckardt K U. Erythropoietin: Karriere eines Hormons. Dtsch Ärzteblatt. 1998; 6 B245-250

PubMed Search in Google Scholar
150 Rationale für den Einsatz von Erythropoetin in der Tumortherapie. Beilage in „Der Onkologe” 2000 6 8

Search in Google Scholar
151 Erythropoietin in der Tumortherapie. Beilage in „Der Onkologe” 1999 5 2

Search in Google Scholar
152 Erythropoietin - neue Aspekte für die Tumortherapie. Beilage in „Der Onkologe” 1999 5 6

Search in Google Scholar
153 Die Bedeutung von Epoetin alfa bei der Behandlung operativer Blutverluste. Expertenmeeting in Wien 7. .4..1995

Search in Google Scholar
154 Goodnough L T, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 2000; 96 823-833

PubMed Search in Google Scholar
155 Scigalla P, Franke W, Messinger D. Rationale für die Eigenblutspende in der elektiven Chirurgie mit oder ohne Einsatz von rekombinanten, humanem Erythropoietin in Innovative Aspekte der klinischen Medizin. Springer 1994 3

Search in Google Scholar
156 Die Rolle von rhErythropoietin im Rahmen fremdblutsparender Methoden. Beilage in „Der Chirurg” 1994 65 4

Search in Google Scholar
157 Rau B, Schlag P M, Willeke F, Herfarth C, Stephan P, Franke W. Increased autologous blood donation in rectal cancer by recombinant human erythropoietin. Eur J Cancer. 1998; 34 992-998

Crossref PubMed Search in Google Scholar
158 Jeekel J. Autologous blood donation and epoetin alfa in cancer surgery. Semin Hematol. 1996; 33 (2 Suppl 2) 43-46, discussion 47

PubMed Search in Google Scholar
159 Ludwig H, Fritz E. Pathogenese und Therapie der therapie- und tumorbedingten Anämie. Kompendium Internistische Onkologie, Springer 1996: 1118-1127

Search in Google Scholar
160 Ludwig H, Fritz E, Leitgeb C, Krainer M, Kührer I, Sagaster P, Umek H. Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ann Oncol. 1993; 4 61-167

PubMed Search in Google Scholar
161 Cazzola M, Mercuriali F, Brugnara C. Use of recombinant erythropoietin outside the setting of uremia. Blood. 1997; 89 4248-4267

PubMed Search in Google Scholar
162 Levine E A, Laborde C, Hambrick E. et al . Influence of Erythropoietin on Transfusion Requirements in Patients Receiving Preoperative Chemoradiotherapy for Rectal Cancer. Dis Colon Rectum. 1999; 42 1065-1071

PubMed Search in Google Scholar
163 Glaser G, Millesi W, Wanschitz F, Schüll B, Lang S, Leitha T, Kornek G V. R-HuErythropoietin treatment increases efficacy of neoadjuvant radiochemotherapy and improves cancer free survival of patients with oral squamous cell carcinoma. Proc Am Soc Clin Oncol. 1999; 18 399a

PubMed Search in Google Scholar
164 Hoeckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996; 56 4509-4515

PubMed Search in Google Scholar
165 Henke M, Guttenberger R. Erythropoietin in Radiation Oncology - A Review. Oncology. 2000; 58 175-182

PubMed Search in Google Scholar
166 Die Bedeutung erhöhter Hämoglobinspiegel für Tumoroxygenierung, Radiotherapie und Prognose. Beilage in „Der Onkologe” 1998 4 3

Search in Google Scholar
167 Glimelius B, Linné T, Hoffmann K. et al . Epoetin Beta in the Treatment of Anemia in Patients With Advanced Gastrointestinal Cancer. J Clin Oncol. 1998; 16 434-440

PubMed Search in Google Scholar
168 Nowrousian M R. Behandlung der tumor- oder chemotherapiebedingten Anämie mit Erythropoietin. Remission 2-99
169 Westphal G. et al .Experimental data concerning safety profile of rhEpo in the treatment of cancer patients. Smith JF, Boogaerts MA and Ehmer BRM (eds) rh Erythropoietin in Cancer Supportive Treatment. 1996: 149-158

Search in Google Scholar
170 Sowade B. et al . The safety of treatment with recombinant humanerythropoietin in clinical use: A review of controlled studies. Int J Mol Med. 1998; 1 303-314

PubMed Search in Google Scholar
171 Weisbach V, Eckstein R. Eisenhaushalt und präoperative Eigenblutspende. Infusionsther Transfusionsmed. 1996; 23 161-170

PubMed Search in Google Scholar
172 Habler O, Kleen M, Meßmer K. Künstliche Sauerstoffträger. Alternativen zur Fremdbluttransfusion?. Zentralbl Chir. 1999; 124 260-270

PubMed Search in Google Scholar

Dr. K. Pfister

Chirurgische Klinik und Poliklinik der Universität Regensburg

Franz-Josef-Strauß-Allee 11

93053 Regensburg

Phone: 0941-9446801

Fax: 0941-9446802

Email: Karin.pfister@Klinik.uni-regensburg.de